NCT03312179View on ClinicalTrials.gov

STEMI and Incretins Treatment

CompletedOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

September 1, 2017

Study Completion Date

October 1, 2017

Conditions
STEMICoronary Artery DiseaseCoronary SyndromeCoronary ArteriosclerosisDiabetes
Interventions
DEVICE

PCI and DES stenting

Percutaneous coronary intervention (PCI) and direct stenting (DES) of culprit lesion vessel.

DRUG

Incretins

Patients treated before study enrollment by incretin drugs (6 months drugs exposure)

Trial Locations (1)

80128

Raffaele Marfella, Naples

All Listed Sponsors
lead

University of Campania Luigi Vanvitelli

OTHER

NCT03312179 - STEMI and Incretins Treatment | Biotech Hunter | Biotech Hunter